Activision Blizzard, Argenx And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures traded mixed this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session.

• Acumen Pharmaceuticals, Inc. ABOS shares jumped 43.9% to $9.03 in pre-market trading after the company presented topline results from Phase 1 study of ACU193 for early Alzheimer's disease at the Alzheimer's Association International Conference 2023.
• argenx SE ARGX shares gained 24.3% to $471.47 in pre-market trading after reporting topline data from ADHERE study of VYVGART Hytrulo in patients with chronic inflammatory demyelinating polyneuropathy.
• BridgeBio Pharma, Inc. BBIO shares rose 20.5% to $21.98 in pre-market trading. BridgeBio Pharma will share topline results from the Phase 3 ATTRibute-CM clinical study in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) on July 17, 2023.
• Zai Lab Limited ZLAB shares climbed 7.7% to $30.00 in pre-market trading. Zai Lab and argenx reported positive topline results from the ADHERE study evaluating VYVGART Hytrulo in adults with chronic inflammatory demyelinating polyneuropathy.
• Lilium N.V. LILM gained 7.6% to $1.42 in pre-market trading. Lilium shares declined 22% on Friday after the company announced pricing of an upsized $192 million offering.
• TeraWulf Inc. WULF shares rose 6.8% to $3.760 in pre-market trading after falling 9% on Friday.
• Quantum-Si incorporated QSI shares surged 6.6% to $2.58 in pre-market trading after declining 6% on Friday.
• Immunovant, Inc. IMVT shares surged 6.3% to $22.05 in pre-market trading.
• MorphoSys AG MOR shares rose 5.5% to $8.27 in pre-market trading after gaining around 4% on Friday.
• Activision Blizzard, Inc. ATVI shares gained 4.3% to $93.95 in pre-market trading after Sony and Microsoft Corp reached a 10-year deal to keep "Call of Duty" games on PlayStation consoles.

Now Read This: FB Financial, Home Bancorp And 3 Stocks To Watch Heading Into Monday

Don’t forget to check out our premarket coverage here